je.st

Home › gilead sciences

Tag: gilead sciences

Gilead Sciences halts drug studies over side effects, death

2016-03-15 23:33:19| Biotech - Topix.net

Biologic drugmaker Gilead Sciences Inc. has halted several patient studies of its cancer drug, Zydelig, because of increased risk of death and serious side effects. The company told The Associated Press the "adverse events" were spotted during an ongoing review of late-stage testing in patients with chronic lymphocytic leukemia, a blood cancer, and patients with relapsed non-Hodgkin's lymphoma, a cancer of the infection-fighting lymphatic system.

Tags: side death effects studies

Valuing Gilead Sciences Based On Free Cash Flow Projections

2016-03-08 21:07:01| Biotech - Topix.net

I anticipate that the company will continue to maintain its competitive advantage for HIV and Hepatitis C products. However, regulatory pressure on pricing remains less certain.

Tags: free based cash flow

Gilead Sciences, Inc. (GILD) Shares Bought by Excalibur Management Corp

2016-03-06 13:53:43| Biotech - Topix.net

Excalibur Management Corp boosted its stake in Gilead Sciences, Inc. by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 29,365 shares of the biopharmaceutical company's stock after buying an additional 365 shares during the period.

Tags: management bought sciences corp

Gilead Sciences beats 4th-quarter forecasts on higher sales

2016-02-03 10:33:31| Biotech - Topix.net

Gilead Sciences Inc. posted a 34 per cent increase in fourth-quarter profit, trouncing Wall Street expectations, as sales of its blockbuster hepatitis C drugs soared in Japan and offset lower sales in the U.S. The maker of Harvoni, the first once-daily, single-pill regimen for hepatitis C, and predecessor drug Sovaldi, has been propelled by the lucrative franchise since Sovaldi was launched at the end of 2013. They're the main reason the company's revenue has tripled in just two years, a rare accomplishment in the industry.

Tags: sales higher sciences beats